Entrada Therapeutics Inc (TRDA) — Working Capital to Net Assets Ratio

Latest as of September 2025: 92.2%

Entrada Therapeutics Inc (TRDA) has a Working Capital to Net Assets ratio of 92.2% as of September 2025. Working capital of $314.24 Million (current assets of $338.26 Million minus current liabilities of $24.02 Million) is measured against net assets of $340.72 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. For the complete balance sheet picture, see Entrada Therapeutics Inc balance sheet assets.

WC/NA Ratio

92.2%
Working Capital / Net Assets

Working Capital

$314.24 Million
USD

Current Assets

$338.26 Million
USD

Current Liabilities

$24.02 Million
USD

Entrada Therapeutics Inc Working Capital to Net Assets (2019–2024)

This chart shows how Entrada Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 6 annual periods from 2019 to 2024. As of September 2025, the ratio stands at 92.2%, reflecting working capital of $314.24 Million against net assets of $340.72 Million USD. Explore Entrada Therapeutics Inc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Annual Working Capital to Net Assets for Entrada Therapeutics Inc (2019–2024)

The table below presents the year-by-year Working Capital to Net Assets ratio for Entrada Therapeutics Inc from 2019 to 2024, covering 6 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Read total liabilities of Entrada Therapeutics Inc for a breakdown of total debt and financial obligations.

Year WC/NA Ratio Working Capital (USD) Net Assets Current Assets Current Liabilities Change (pp)
2024 93.4% $400.56 Million $428.68 Million $440.04 Million $39.48 Million ▲ +6.4 pp
2023 87.1% $210.97 Million $242.36 Million $369.77 Million $158.80 Million ▼ -1.4 pp
2022 88.4% $187.90 Million $212.55 Million $209.88 Million $21.97 Million ▼ -9.3 pp
2021 97.7% $291.98 Million $298.72 Million $298.70 Million $6.72 Million ▲ +185.9 pp
2020 -88.2% $36.59 Million $-41.49 Million $39.95 Million $3.36 Million ▲ +11.8 pp
2019 -100.0% $15.52 Million $-15.52 Million $17.44 Million $1.92 Million
pp = percentage points